Skip to main content

Table 1 SLC13A5 mutations associated with epilepsy.

From: Mutations in the Na+/Citrate Cotransporter NaCT (SLC13A5) in Pediatric Patients with Epilepsy and Developmental Delay

Family

cDNA change

Protein change

Zygosity

Number of patients

Reference

This study:

A

c. 655 G > A

p. G219R

Heterozygous

2

 
 

c.1475T> C

p. L492P

   

B

c. 680 C > T

p. T227M

Homozygous

1

 

C

c. 245 A > G

p. Y82C

Heterozygous

2

 
 

c. 655 G > A

p. G219R

   

D

c. 511delG

p. E171SfsX16

Homozygous

1

 
 

(DelG)

    

E

c. 1276-1G > A

Affect splice site

Heterozygous

2

 
 

c. 103-1G > A

& add intron**

   

F

c. 655 G > A

p. G219R

Homozygous

1

 

Previous studies:

A

c. 1280 C > T

p. S427L

Homozygous

 

(3)

B

c. 1022 G > A

p. T341*

Heterozygous

 

(3)

 

c. 1207_1217dupl 1

p. P407Rfs*12

   

C

c. 425 C > T

p. T142M

Heterozygous

 

(3)

 

c. 655 G > A

p. G219R

   

D

c. 680 C > T

p. T227M

Heterozygous

 

(3)

 

c. 1570 G > C

p. D524H

   

1

c. 655 G > A

p. G219R

Heterozygous

 

(2)

 

c. 680 C > T

p. T227M

   

2

c. 1463T > C

p. L488P

Homozygous

 

(2)

3

c. 655G > A

p. G219R

Heterozygous

 

(2)

 

c. 680C > T

p. T227M

   
  1. ** Describes mRNA changes as a result of cDNA change.